Total Payments
$11,017
2024 Payments
$353.44
Companies
23
Transactions
181
Medicare Patients
1,357
Medicare Billing
$160,312
Payment Breakdown by Category
Consulting$4,450 (40.4%)
Food & Beverage$4,218 (38.3%)
Travel$2,269 (20.6%)
Education$79.90 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,450 | 2 | 40.4% |
| Food and Beverage | $4,218 | 171 | 38.3% |
| Travel and Lodging | $2,269 | 6 | 20.6% |
| Education | $79.90 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Accelerate Diagnostics Inc. | $7,760 | 12 | $0 (2019) |
| Merck Sharp & Dohme LLC | $572.07 | 32 | $0 (2024) |
| Astellas Pharma US Inc | $453.65 | 26 | $0 (2024) |
| Melinta Therapeutics, LLC | $434.19 | 20 | $0 (2024) |
| ABBVIE INC. | $314.67 | 16 | $0 (2024) |
| Gilead Sciences, Inc. | $313.76 | 16 | $0 (2023) |
| Shionogi Inc | $254.10 | 10 | $0 (2024) |
| Allergan, Inc. | $200.68 | 14 | $0 (2020) |
| Janssen Biotech, Inc. | $139.51 | 8 | $0 (2023) |
| ExThera Medical Corporation | $101.17 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $353.44 | 16 | Merck Sharp & Dohme LLC ($83.70) |
| 2023 | $462.53 | 21 | Shionogi Inc ($108.84) |
| 2022 | $585.65 | 29 | ABBVIE INC. ($142.00) |
| 2021 | $409.40 | 19 | ExThera Medical Corporation ($101.17) |
| 2020 | $363.97 | 21 | Astellas Pharma US Inc ($148.95) |
| 2019 | $1,209 | 42 | Accelerate Diagnostics Inc. ($500.00) |
| 2018 | $1,103 | 15 | Accelerate Diagnostics Inc. ($885.20) |
| 2017 | $6,530 | 18 | Accelerate Diagnostics Inc. ($6,375) |
All Payment Transactions
181 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $31.14 | General |
| Category: Infections and Infectious Diseases | ||||||
| 11/06/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: GI | ||||||
| 10/22/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/07/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: ANTIFUNGALS | ||||||
| 07/17/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: HIV | ||||||
| 07/08/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $30.48 | General |
| Category: Infections and Infectious Diseases | ||||||
| 06/26/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/15/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/01/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/25/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Infectious Diseases | ||||||
| 04/17/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/14/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $29.92 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/13/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/28/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: ANTIFUNGALS | ||||||
| 01/11/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/22/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Infections and Infectious Diseases | ||||||
| 11/15/2023 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Infectious Diseases | ||||||
| 10/11/2023 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/16/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: ANTIBIOTIC | ||||||
| 07/12/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: HIV | ||||||
| 06/28/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 06/27/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/21/2023 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/22/2023 | Melinta Therapeutics, LLC | Vabomere (Drug), Kimyrsa | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: ANTIBIOTICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 245 | 392 | $108,103 | $33,206 |
| 2022 | 6 | 299 | 400 | $114,486 | $33,029 |
| 2021 | 5 | 356 | 500 | $125,224 | $41,003 |
| 2020 | 6 | 457 | 639 | $164,769 | $53,074 |
Total Patients
1,357
Total Services
1,931
Medicare Billing
$160,312
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 64 | 163 | $36,320 | $14,460 | 39.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 81 | 127 | $28,340 | $7,394 | 26.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 51 | 51 | $25,755 | $6,498 | 25.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 49 | 51 | $17,688 | $4,855 | 27.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 77 | 77 | $40,487 | $11,531 | 28.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 112 | 168 | $31,562 | $8,929 | 28.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 45 | 81 | $21,275 | $5,988 | 28.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 38 | $13,098 | $3,968 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 20 | $3,780 | $1,369 | 36.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 16 | 16 | $4,284 | $1,244 | 29.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 142 | 223 | $37,910 | $12,168 | 32.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 73 | 76 | $36,404 | $11,715 | 32.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 56 | 103 | $25,235 | $8,219 | 32.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 54 | 57 | $18,582 | $6,048 | 32.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 41 | $7,093 | $2,853 | 40.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 112 | 113 | $54,127 | $17,441 | 32.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 139 | 217 | $36,890 | $12,051 | 32.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 81 | 136 | $33,320 | $11,049 | 33.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 53 | 57 | $18,582 | $5,652 | 30.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 58 | 94 | $16,262 | $5,038 | 31.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 22 | $5,588 | $1,844 | 33.0% |
About Dr. Ioana Chirca, MD
Dr. Ioana Chirca, MD is a Internal Medicine healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2011. The National Provider Identifier (NPI) number assigned to this provider is 1932494077.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ioana Chirca, MD has received a total of $11,017 in payments from pharmaceutical and medical device companies, with $353.44 received in 2024. These payments were reported across 181 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($4,450).
As a Medicare-enrolled provider, Chirca has provided services to 1,357 Medicare beneficiaries, totaling 1,931 services with total Medicare billing of $160,312. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Augusta, GA
- Active Since 06/16/2011
- Last Updated 02/21/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1932494077
Products in Payments
- ACCELERATE PHENO (Device) $7,760
- AVYCAZ (Drug) $328.52
- Fetroja (Drug) $254.10
- CRESEMBA (Drug) $164.68
- ISENTRESS (Drug) $163.27
- Vabomere (Drug) $156.40
- MYCAMINE (Drug) $152.36
- SYMTUZA (Drug) $139.51
- DIFICID (Drug) $138.53
- Kimyrsa (Drug) $111.81
- Seraph 100 Micobind Affinity Filter (Device) $101.17
- ZERBAXA (Drug) $89.99
- MAVYRET (Drug) $88.53
- PIFELTRO (Drug) $87.58
- NUZYRA (Drug) $71.94
- TEFLARO (Drug) $69.57
- Orbactiv (Drug) $68.36
- Baxdela (Drug) $59.66
- LOKELMA (Drug) $52.71
- MINOCIN IV (Drug) $41.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Augusta
Jose Vazquez, M.d, M.D
Internal Medicine — Payments: $385,849
Internal Medicine $385,849
Satish Rao, Md Phd, MD PHD
Internal Medicine — Payments: $311,272
Internal Medicine $311,272
Dr. Oladapo Fawibe, Md, MD
Internal Medicine — Payments: $88,504
Internal Medicine $88,504
Charlene Rohm, M.d, M.D
Internal Medicine — Payments: $64,035
Internal Medicine $64,035
Dr. William White, M.d, M.D
Internal Medicine — Payments: $42,427
Internal Medicine $42,427
Dr. Joseph Lightsey, M.d, M.D
Internal Medicine — Payments: $39,432
Internal Medicine $39,432